nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—Parkinson's disease—Clonazepam—epilepsy syndrome	0.182	0.554	CpDpCtD
Bromocriptine—Parkinson's disease—Gabapentin—epilepsy syndrome	0.147	0.446	CpDpCtD
Bromocriptine—HTR7—epilepsy syndrome	0.0882	0.372	CbGaD
Bromocriptine—ADRA2A—epilepsy syndrome	0.0756	0.319	CbGaD
Bromocriptine—HTR2A—epilepsy syndrome	0.0443	0.187	CbGaD
Bromocriptine—ABCB1—epilepsy syndrome	0.0289	0.122	CbGaD
Bromocriptine—ABCB1—Levetiracetam—epilepsy syndrome	0.0123	0.0701	CbGbCtD
Bromocriptine—ABCB1—Clobazam—epilepsy syndrome	0.00852	0.0486	CbGbCtD
Bromocriptine—ABCB1—Lamotrigine—epilepsy syndrome	0.0082	0.0468	CbGbCtD
Bromocriptine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00808	0.046	CbGbCtD
Bromocriptine—CYP1A2—Primidone—epilepsy syndrome	0.00754	0.043	CbGbCtD
Bromocriptine—ABCB1—Carbamazepine—epilepsy syndrome	0.00706	0.0402	CbGbCtD
Bromocriptine—CYP1A2—Propofol—epilepsy syndrome	0.00676	0.0385	CbGbCtD
Bromocriptine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00674	0.0384	CbGbCtD
Bromocriptine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00646	0.0368	CbGbCtD
Bromocriptine—ABCB1—Phenytoin—epilepsy syndrome	0.00633	0.0361	CbGbCtD
Bromocriptine—CYP3A4—Trimethadione—epilepsy syndrome	0.00626	0.0357	CbGbCtD
Bromocriptine—CYP3A4—Felbamate—epilepsy syndrome	0.00626	0.0357	CbGbCtD
Bromocriptine—CYP1A2—Diazepam—epilepsy syndrome	0.00612	0.0349	CbGbCtD
Bromocriptine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00589	0.0336	CbGbCtD
Bromocriptine—ABCB1—Phenobarbital—epilepsy syndrome	0.00565	0.0322	CbGbCtD
Bromocriptine—ABCB1—Midazolam—epilepsy syndrome	0.00557	0.0317	CbGbCtD
Bromocriptine—ABCB1—Diazepam—epilepsy syndrome	0.00535	0.0305	CbGbCtD
Bromocriptine—CYP3A4—Clonazepam—epilepsy syndrome	0.00533	0.0304	CbGbCtD
Bromocriptine—CYP3A4—Clobazam—epilepsy syndrome	0.00511	0.0291	CbGbCtD
Bromocriptine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00482	0.0275	CbGbCtD
Bromocriptine—CYP3A4—Rufinamide—epilepsy syndrome	0.00434	0.0247	CbGbCtD
Bromocriptine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00423	0.0241	CbGbCtD
Bromocriptine—CYP3A4—Primidone—epilepsy syndrome	0.00395	0.0225	CbGbCtD
Bromocriptine—HTR1D—meninx—epilepsy syndrome	0.00382	0.0759	CbGeAlD
Bromocriptine—CYP3A4—Phenytoin—epilepsy syndrome	0.00379	0.0216	CbGbCtD
Bromocriptine—CYP3A4—Propofol—epilepsy syndrome	0.00354	0.0202	CbGbCtD
Bromocriptine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00338	0.0193	CbGbCtD
Bromocriptine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00338	0.0193	CbGbCtD
Bromocriptine—CYP3A4—Midazolam—epilepsy syndrome	0.00334	0.019	CbGbCtD
Bromocriptine—CYP3A4—Diazepam—epilepsy syndrome	0.00321	0.0183	CbGbCtD
Bromocriptine—CYP3A4—Zonisamide—epilepsy syndrome	0.00313	0.0178	CbGbCtD
Bromocriptine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00253	0.0144	CbGbCtD
Bromocriptine—CYP3A4—Topiramate—epilepsy syndrome	0.00228	0.013	CbGbCtD
Bromocriptine—HTR2A—phrenic nerve—epilepsy syndrome	0.00205	0.0408	CbGeAlD
Bromocriptine—DRD3—telencephalic ventricle—epilepsy syndrome	0.00156	0.031	CbGeAlD
Bromocriptine—HTR7—locus ceruleus—epilepsy syndrome	0.00147	0.0292	CbGeAlD
Bromocriptine—HTR7—vagus nerve—epilepsy syndrome	0.00113	0.0224	CbGeAlD
Bromocriptine—DRD1—telencephalic ventricle—epilepsy syndrome	0.00112	0.0222	CbGeAlD
Bromocriptine—HTR6—ganglion—epilepsy syndrome	0.000934	0.0186	CbGeAlD
Bromocriptine—HTR2A—locus ceruleus—epilepsy syndrome	0.000917	0.0182	CbGeAlD
Bromocriptine—DRD5—ganglion—epilepsy syndrome	0.00091	0.0181	CbGeAlD
Bromocriptine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000905	0.018	CbGeAlD
Bromocriptine—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000876	0.0174	CbGeAlD
Bromocriptine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000867	0.0172	CbGeAlD
Bromocriptine—HTR7—pons—epilepsy syndrome	0.000848	0.0168	CbGeAlD
Bromocriptine—HTR7—autonomic nervous system—epilepsy syndrome	0.000782	0.0155	CbGeAlD
Bromocriptine—HTR2A—cerebellar cortex—epilepsy syndrome	0.000748	0.0149	CbGeAlD
Bromocriptine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00073	0.0145	CbGeAlD
Bromocriptine—HTR2A—vagus nerve—epilepsy syndrome	0.000702	0.014	CbGeAlD
Bromocriptine—HTR7—telencephalic ventricle—epilepsy syndrome	0.000698	0.0139	CbGeAlD
Bromocriptine—DRD1—ganglion—epilepsy syndrome	0.000695	0.0138	CbGeAlD
Bromocriptine—DRD2—telencephalic ventricle—epilepsy syndrome	0.00066	0.0131	CbGeAlD
Bromocriptine—HTR1B—ganglion—epilepsy syndrome	0.000563	0.0112	CbGeAlD
Bromocriptine—HTR1D—ganglion—epilepsy syndrome	0.000545	0.0108	CbGeAlD
Bromocriptine—HTR2C—ganglion—epilepsy syndrome	0.00054	0.0107	CbGeAlD
Bromocriptine—HTR2A—pons—epilepsy syndrome	0.000529	0.0105	CbGeAlD
Bromocriptine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000488	0.00969	CbGeAlD
Bromocriptine—HTR1A—ganglion—epilepsy syndrome	0.000454	0.00903	CbGeAlD
Bromocriptine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000435	0.00864	CbGeAlD
Bromocriptine—HTR7—ganglion—epilepsy syndrome	0.000434	0.00863	CbGeAlD
Bromocriptine—DRD2—ganglion—epilepsy syndrome	0.000411	0.00816	CbGeAlD
Bromocriptine—HTR6—forebrain—epilepsy syndrome	0.000392	0.00779	CbGeAlD
Bromocriptine—DRD5—forebrain—epilepsy syndrome	0.000382	0.00758	CbGeAlD
Bromocriptine—Dihydroergotamine—ADRA2A—epilepsy syndrome	0.00037	0.228	CrCbGaD
Bromocriptine—HTR6—telencephalon—epilepsy syndrome	0.00036	0.00716	CbGeAlD
Bromocriptine—DRD5—telencephalon—epilepsy syndrome	0.000351	0.00697	CbGeAlD
Bromocriptine—HTR1A—hindbrain—epilepsy syndrome	0.000345	0.00685	CbGeAlD
Bromocriptine—HTR7—hindbrain—epilepsy syndrome	0.000329	0.00654	CbGeAlD
Bromocriptine—ADRA1A—hindbrain—epilepsy syndrome	0.000318	0.00631	CbGeAlD
Bromocriptine—DRD2—hindbrain—epilepsy syndrome	0.000311	0.00619	CbGeAlD
Bromocriptine—ADRA1D—forebrain—epilepsy syndrome	0.000306	0.00608	CbGeAlD
Bromocriptine—DRD1—brainstem—epilepsy syndrome	0.000302	0.006	CbGeAlD
Bromocriptine—DRD1—forebrain—epilepsy syndrome	0.000292	0.00579	CbGeAlD
Bromocriptine—Methysergide—HTR7—epilepsy syndrome	0.000287	0.177	CrCbGaD
Bromocriptine—ADRA1D—telencephalon—epilepsy syndrome	0.000281	0.00559	CbGeAlD
Bromocriptine—HTR2A—ganglion—epilepsy syndrome	0.000271	0.00538	CbGeAlD
Bromocriptine—DRD1—telencephalon—epilepsy syndrome	0.000268	0.00533	CbGeAlD
Bromocriptine—HTR1B—brainstem—epilepsy syndrome	0.000245	0.00486	CbGeAlD
Bromocriptine—DRD4—brain—epilepsy syndrome	0.00024	0.00478	CbGeAlD
Bromocriptine—HTR1D—brainstem—epilepsy syndrome	0.000237	0.00471	CbGeAlD
Bromocriptine—HTR1B—forebrain—epilepsy syndrome	0.000236	0.00469	CbGeAlD
Bromocriptine—HTR2C—brainstem—epilepsy syndrome	0.000235	0.00466	CbGeAlD
Bromocriptine—DRD3—head—epilepsy syndrome	0.000233	0.00463	CbGeAlD
Bromocriptine—HTR1D—forebrain—epilepsy syndrome	0.000229	0.00454	CbGeAlD
Bromocriptine—HTR2C—forebrain—epilepsy syndrome	0.000226	0.0045	CbGeAlD
Bromocriptine—HTR6—head—epilepsy syndrome	0.000224	0.00446	CbGeAlD
Bromocriptine—ADRB1—forebrain—epilepsy syndrome	0.000222	0.00442	CbGeAlD
Bromocriptine—DRD3—nervous system—epilepsy syndrome	0.000221	0.00439	CbGeAlD
Bromocriptine—DRD5—head—epilepsy syndrome	0.000218	0.00434	CbGeAlD
Bromocriptine—HTR1B—telencephalon—epilepsy syndrome	0.000217	0.00432	CbGeAlD
Bromocriptine—DRD3—central nervous system—epilepsy syndrome	0.000213	0.00423	CbGeAlD
Bromocriptine—HTR6—nervous system—epilepsy syndrome	0.000213	0.00423	CbGeAlD
Bromocriptine—HTR2B—forebrain—epilepsy syndrome	0.000213	0.00423	CbGeAlD
Bromocriptine—HTR1D—telencephalon—epilepsy syndrome	0.00021	0.00418	CbGeAlD
Bromocriptine—HTR2C—telencephalon—epilepsy syndrome	0.000208	0.00414	CbGeAlD
Bromocriptine—DRD5—nervous system—epilepsy syndrome	0.000207	0.00412	CbGeAlD
Bromocriptine—HTR2A—hindbrain—epilepsy syndrome	0.000205	0.00408	CbGeAlD
Bromocriptine—HTR6—central nervous system—epilepsy syndrome	0.000205	0.00407	CbGeAlD
Bromocriptine—ADRB1—telencephalon—epilepsy syndrome	0.000204	0.00406	CbGeAlD
Bromocriptine—DRD5—central nervous system—epilepsy syndrome	0.000199	0.00396	CbGeAlD
Bromocriptine—HTR1A—brainstem—epilepsy syndrome	0.000198	0.00392	CbGeAlD
Bromocriptine—HTR2B—telencephalon—epilepsy syndrome	0.000196	0.00389	CbGeAlD
Bromocriptine—DRD1—midbrain—epilepsy syndrome	0.000193	0.00383	CbGeAlD
Bromocriptine—HTR1A—forebrain—epilepsy syndrome	0.000191	0.00379	CbGeAlD
Bromocriptine—Ergotamine—ADRA2A—epilepsy syndrome	0.00019	0.117	CrCbGaD
Bromocriptine—HTR7—brainstem—epilepsy syndrome	0.000189	0.00375	CbGeAlD
Bromocriptine—HTR7—forebrain—epilepsy syndrome	0.000182	0.00362	CbGeAlD
Bromocriptine—ADRA1A—brainstem—epilepsy syndrome	0.000182	0.00362	CbGeAlD
Bromocriptine—ADRA1B—head—epilepsy syndrome	0.000179	0.00356	CbGeAlD
Bromocriptine—DRD2—brainstem—epilepsy syndrome	0.000178	0.00355	CbGeAlD
Bromocriptine—ADRA1A—forebrain—epilepsy syndrome	0.000176	0.00349	CbGeAlD
Bromocriptine—HTR1A—telencephalon—epilepsy syndrome	0.000175	0.00348	CbGeAlD
Bromocriptine—ADRA1D—head—epilepsy syndrome	0.000175	0.00348	CbGeAlD
Bromocriptine—Methylergometrine—HTR2A—epilepsy syndrome	0.000173	0.107	CrCbGaD
Bromocriptine—DRD2—forebrain—epilepsy syndrome	0.000172	0.00342	CbGeAlD
Bromocriptine—ADRA1B—nervous system—epilepsy syndrome	0.00017	0.00337	CbGeAlD
Bromocriptine—DRD3—brain—epilepsy syndrome	0.000169	0.00336	CbGeAlD
Bromocriptine—HTR7—telencephalon—epilepsy syndrome	0.000168	0.00333	CbGeAlD
Bromocriptine—DRD1—head—epilepsy syndrome	0.000167	0.00332	CbGeAlD
Bromocriptine—ADRA1D—nervous system—epilepsy syndrome	0.000166	0.0033	CbGeAlD
Bromocriptine—HTR2C—medulla oblongata—epilepsy syndrome	0.000164	0.00325	CbGeAlD
Bromocriptine—ADRA1B—central nervous system—epilepsy syndrome	0.000163	0.00325	CbGeAlD
Bromocriptine—HTR6—brain—epilepsy syndrome	0.000163	0.00323	CbGeAlD
Bromocriptine—ADRA1A—telencephalon—epilepsy syndrome	0.000162	0.00321	CbGeAlD
Bromocriptine—ADRA1D—central nervous system—epilepsy syndrome	0.00016	0.00318	CbGeAlD
Bromocriptine—DRD2—telencephalon—epilepsy syndrome	0.000158	0.00315	CbGeAlD
Bromocriptine—DRD5—brain—epilepsy syndrome	0.000158	0.00315	CbGeAlD
Bromocriptine—DRD1—nervous system—epilepsy syndrome	0.000158	0.00314	CbGeAlD
Bromocriptine—HTR1B—midbrain—epilepsy syndrome	0.000156	0.0031	CbGeAlD
Bromocriptine—ADRA2C—telencephalon—epilepsy syndrome	0.000154	0.00306	CbGeAlD
Bromocriptine—DRD1—central nervous system—epilepsy syndrome	0.000152	0.00303	CbGeAlD
Bromocriptine—HTR1B—spinal cord—epilepsy syndrome	0.000152	0.00302	CbGeAlD
Bromocriptine—HTR1D—midbrain—epilepsy syndrome	0.000151	0.003	CbGeAlD
Bromocriptine—HTR2C—midbrain—epilepsy syndrome	0.00015	0.00297	CbGeAlD
Bromocriptine—HTR2C—spinal cord—epilepsy syndrome	0.000146	0.0029	CbGeAlD
Bromocriptine—Methysergide—HTR2A—epilepsy syndrome	0.000145	0.0892	CrCbGaD
Bromocriptine—Dihydroergotamine—ABCB1—epilepsy syndrome	0.000141	0.0873	CrCbGaD
Bromocriptine—HTR1B—head—epilepsy syndrome	0.000135	0.00269	CbGeAlD
Bromocriptine—ADRA2A—forebrain—epilepsy syndrome	0.000134	0.00265	CbGeAlD
Bromocriptine—HTR7—medulla oblongata—epilepsy syndrome	0.000132	0.00262	CbGeAlD
Bromocriptine—HTR1D—head—epilepsy syndrome	0.000131	0.0026	CbGeAlD
Bromocriptine—ADRA1B—brain—epilepsy syndrome	0.00013	0.00258	CbGeAlD
Bromocriptine—HTR2C—head—epilepsy syndrome	0.00013	0.00258	CbGeAlD
Bromocriptine—Ergonovine—ABCB1—epilepsy syndrome	0.000129	0.0798	CrCbGaD
Bromocriptine—HTR1B—nervous system—epilepsy syndrome	0.000128	0.00255	CbGeAlD
Bromocriptine—ADRB1—head—epilepsy syndrome	0.000127	0.00253	CbGeAlD
Bromocriptine—ADRA1D—brain—epilepsy syndrome	0.000127	0.00252	CbGeAlD
Bromocriptine—HTR1A—midbrain—epilepsy syndrome	0.000126	0.0025	CbGeAlD
Bromocriptine—HTR1D—nervous system—epilepsy syndrome	0.000124	0.00247	CbGeAlD
Bromocriptine—HTR1B—central nervous system—epilepsy syndrome	0.000123	0.00245	CbGeAlD
Bromocriptine—HTR2C—nervous system—epilepsy syndrome	0.000123	0.00244	CbGeAlD
Bromocriptine—ADRA2A—telencephalon—epilepsy syndrome	0.000123	0.00244	CbGeAlD
Bromocriptine—HTR1A—spinal cord—epilepsy syndrome	0.000123	0.00244	CbGeAlD
Bromocriptine—HTR2B—head—epilepsy syndrome	0.000122	0.00242	CbGeAlD
Bromocriptine—ADRA2C—medulla oblongata—epilepsy syndrome	0.000121	0.0024	CbGeAlD
Bromocriptine—DRD1—brain—epilepsy syndrome	0.000121	0.0024	CbGeAlD
Bromocriptine—ADRB1—nervous system—epilepsy syndrome	0.000121	0.0024	CbGeAlD
Bromocriptine—HTR7—midbrain—epilepsy syndrome	0.00012	0.00239	CbGeAlD
Bromocriptine—HTR1D—central nervous system—epilepsy syndrome	0.00012	0.00238	CbGeAlD
Bromocriptine—HTR2C—central nervous system—epilepsy syndrome	0.000118	0.00235	CbGeAlD
Bromocriptine—HTR2A—brainstem—epilepsy syndrome	0.000118	0.00234	CbGeAlD
Bromocriptine—HTR7—spinal cord—epilepsy syndrome	0.000117	0.00233	CbGeAlD
Bromocriptine—ADRB1—central nervous system—epilepsy syndrome	0.000116	0.00231	CbGeAlD
Bromocriptine—HTR2B—nervous system—epilepsy syndrome	0.000115	0.00229	CbGeAlD
Bromocriptine—DRD2—midbrain—epilepsy syndrome	0.000114	0.00226	CbGeAlD
Bromocriptine—HTR2A—forebrain—epilepsy syndrome	0.000114	0.00226	CbGeAlD
Bromocriptine—Ergotamine—HTR2A—epilepsy syndrome	0.000112	0.0689	CrCbGaD
Bromocriptine—HTR2B—central nervous system—epilepsy syndrome	0.000111	0.00221	CbGeAlD
Bromocriptine—ADRA2C—midbrain—epilepsy syndrome	0.000111	0.0022	CbGeAlD
Bromocriptine—HTR1A—head—epilepsy syndrome	0.000109	0.00217	CbGeAlD
Bromocriptine—ADRA2C—spinal cord—epilepsy syndrome	0.000108	0.00214	CbGeAlD
Bromocriptine—HTR2A—telencephalon—epilepsy syndrome	0.000104	0.00208	CbGeAlD
Bromocriptine—HTR7—head—epilepsy syndrome	0.000104	0.00207	CbGeAlD
Bromocriptine—HTR1A—nervous system—epilepsy syndrome	0.000103	0.00206	CbGeAlD
Bromocriptine—ADRA1A—head—epilepsy syndrome	0.000101	0.002	CbGeAlD
Bromocriptine—HTR1A—central nervous system—epilepsy syndrome	9.96e-05	0.00198	CbGeAlD
Bromocriptine—HTR7—nervous system—epilepsy syndrome	9.89e-05	0.00197	CbGeAlD
Bromocriptine—DRD2—head—epilepsy syndrome	9.86e-05	0.00196	CbGeAlD
Bromocriptine—HTR1B—brain—epilepsy syndrome	9.8e-05	0.00195	CbGeAlD
Bromocriptine—HTR1A—cerebellum—epilepsy syndrome	9.74e-05	0.00193	CbGeAlD
Bromocriptine—ADRA2A—medulla oblongata—epilepsy syndrome	9.65e-05	0.00192	CbGeAlD
Bromocriptine—ADRA2C—head—epilepsy syndrome	9.59e-05	0.00191	CbGeAlD
Bromocriptine—ADRA1A—nervous system—epilepsy syndrome	9.54e-05	0.0019	CbGeAlD
Bromocriptine—HTR7—central nervous system—epilepsy syndrome	9.52e-05	0.00189	CbGeAlD
Bromocriptine—HTR1D—brain—epilepsy syndrome	9.49e-05	0.00189	CbGeAlD
Bromocriptine—HTR2C—brain—epilepsy syndrome	9.4e-05	0.00187	CbGeAlD
Bromocriptine—DRD2—nervous system—epilepsy syndrome	9.35e-05	0.00186	CbGeAlD
Bromocriptine—HTR7—cerebellum—epilepsy syndrome	9.31e-05	0.00185	CbGeAlD
Bromocriptine—ADRB1—brain—epilepsy syndrome	9.22e-05	0.00183	CbGeAlD
Bromocriptine—ADRA1A—central nervous system—epilepsy syndrome	9.18e-05	0.00182	CbGeAlD
Bromocriptine—ADRA2C—nervous system—epilepsy syndrome	9.09e-05	0.00181	CbGeAlD
Bromocriptine—DRD2—central nervous system—epilepsy syndrome	9e-05	0.00179	CbGeAlD
Bromocriptine—ADRA1A—cerebellum—epilepsy syndrome	8.98e-05	0.00178	CbGeAlD
Bromocriptine—HTR2B—brain—epilepsy syndrome	8.83e-05	0.00175	CbGeAlD
Bromocriptine—ADRA2A—midbrain—epilepsy syndrome	8.82e-05	0.00175	CbGeAlD
Bromocriptine—DRD2—cerebellum—epilepsy syndrome	8.8e-05	0.00175	CbGeAlD
Bromocriptine—ADRA2C—central nervous system—epilepsy syndrome	8.75e-05	0.00174	CbGeAlD
Bromocriptine—ADRA2A—spinal cord—epilepsy syndrome	8.61e-05	0.00171	CbGeAlD
Bromocriptine—ADRA2C—cerebellum—epilepsy syndrome	8.55e-05	0.0017	CbGeAlD
Bromocriptine—HTR2A—medulla oblongata—epilepsy syndrome	8.21e-05	0.00163	CbGeAlD
Bromocriptine—HTR1A—brain—epilepsy syndrome	7.91e-05	0.00157	CbGeAlD
Bromocriptine—ADRA2A—head—epilepsy syndrome	7.65e-05	0.00152	CbGeAlD
Bromocriptine—HTR7—brain—epilepsy syndrome	7.56e-05	0.0015	CbGeAlD
Bromocriptine—HTR2A—midbrain—epilepsy syndrome	7.5e-05	0.00149	CbGeAlD
Bromocriptine—ABCB1—forebrain—epilepsy syndrome	7.45e-05	0.00148	CbGeAlD
Bromocriptine—HTR2A—spinal cord—epilepsy syndrome	7.32e-05	0.00145	CbGeAlD
Bromocriptine—ADRA1A—brain—epilepsy syndrome	7.29e-05	0.00145	CbGeAlD
Bromocriptine—Ergotamine—ABCB1—epilepsy syndrome	7.29e-05	0.045	CrCbGaD
Bromocriptine—ADRA2A—nervous system—epilepsy syndrome	7.25e-05	0.00144	CbGeAlD
Bromocriptine—DRD2—brain—epilepsy syndrome	7.15e-05	0.00142	CbGeAlD
Bromocriptine—ADRA2A—central nervous system—epilepsy syndrome	6.98e-05	0.00139	CbGeAlD
Bromocriptine—ADRA2C—brain—epilepsy syndrome	6.95e-05	0.00138	CbGeAlD
Bromocriptine—ABCB1—telencephalon—epilepsy syndrome	6.85e-05	0.00136	CbGeAlD
Bromocriptine—ADRA2A—cerebellum—epilepsy syndrome	6.83e-05	0.00136	CbGeAlD
Bromocriptine—HTR2A—head—epilepsy syndrome	6.51e-05	0.00129	CbGeAlD
Bromocriptine—HTR2A—nervous system—epilepsy syndrome	6.17e-05	0.00123	CbGeAlD
Bromocriptine—HTR2A—central nervous system—epilepsy syndrome	5.94e-05	0.00118	CbGeAlD
Bromocriptine—HTR2A—cerebellum—epilepsy syndrome	5.8e-05	0.00115	CbGeAlD
Bromocriptine—CYP3A4—nervous system—epilepsy syndrome	5.71e-05	0.00113	CbGeAlD
Bromocriptine—ADRA2A—brain—epilepsy syndrome	5.54e-05	0.0011	CbGeAlD
Bromocriptine—CYP3A4—central nervous system—epilepsy syndrome	5.5e-05	0.00109	CbGeAlD
Bromocriptine—ABCB1—medulla oblongata—epilepsy syndrome	5.38e-05	0.00107	CbGeAlD
Bromocriptine—ABCB1—midbrain—epilepsy syndrome	4.92e-05	0.000977	CbGeAlD
Bromocriptine—ABCB1—spinal cord—epilepsy syndrome	4.8e-05	0.000953	CbGeAlD
Bromocriptine—HTR2A—brain—epilepsy syndrome	4.71e-05	0.000937	CbGeAlD
Bromocriptine—ABCB1—head—epilepsy syndrome	4.26e-05	0.000847	CbGeAlD
Bromocriptine—ABCB1—nervous system—epilepsy syndrome	4.04e-05	0.000803	CbGeAlD
Bromocriptine—ABCB1—central nervous system—epilepsy syndrome	3.89e-05	0.000773	CbGeAlD
Bromocriptine—ABCB1—cerebellum—epilepsy syndrome	3.8e-05	0.000756	CbGeAlD
Bromocriptine—Headache—Levetiracetam—epilepsy syndrome	3.77e-05	0.000313	CcSEcCtD
Bromocriptine—Dizziness—Vigabatrin—epilepsy syndrome	3.74e-05	0.000311	CcSEcCtD
Bromocriptine—Confusional state—Valproic Acid—epilepsy syndrome	3.73e-05	0.00031	CcSEcCtD
Bromocriptine—Oedema—Valproic Acid—epilepsy syndrome	3.7e-05	0.000308	CcSEcCtD
Bromocriptine—Urticaria—Lamotrigine—epilepsy syndrome	3.7e-05	0.000308	CcSEcCtD
Bromocriptine—Bradycardia—Topiramate—epilepsy syndrome	3.7e-05	0.000308	CcSEcCtD
Bromocriptine—Nausea—Propofol—epilepsy syndrome	3.7e-05	0.000307	CcSEcCtD
Bromocriptine—Tension—Gabapentin—epilepsy syndrome	3.69e-05	0.000307	CcSEcCtD
Bromocriptine—Vomiting—Fosphenytoin—epilepsy syndrome	3.69e-05	0.000307	CcSEcCtD
Bromocriptine—Diarrhoea—Felbamate—epilepsy syndrome	3.69e-05	0.000307	CcSEcCtD
Bromocriptine—Vertigo—Pregabalin—epilepsy syndrome	3.69e-05	0.000306	CcSEcCtD
Bromocriptine—Body temperature increased—Lamotrigine—epilepsy syndrome	3.68e-05	0.000306	CcSEcCtD
Bromocriptine—Abdominal pain—Lamotrigine—epilepsy syndrome	3.68e-05	0.000306	CcSEcCtD
Bromocriptine—Dysgeusia—Gabapentin—epilepsy syndrome	3.68e-05	0.000306	CcSEcCtD
Bromocriptine—Dizziness—Diazepam—epilepsy syndrome	3.68e-05	0.000306	CcSEcCtD
Bromocriptine—Infection—Valproic Acid—epilepsy syndrome	3.68e-05	0.000306	CcSEcCtD
Bromocriptine—Syncope—Pregabalin—epilepsy syndrome	3.68e-05	0.000306	CcSEcCtD
Bromocriptine—Rash—Fosphenytoin—epilepsy syndrome	3.66e-05	0.000304	CcSEcCtD
Bromocriptine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.66e-05	0.000304	CcSEcCtD
Bromocriptine—Nervousness—Gabapentin—epilepsy syndrome	3.65e-05	0.000304	CcSEcCtD
Bromocriptine—Asthenia—Clonazepam—epilepsy syndrome	3.65e-05	0.000303	CcSEcCtD
Bromocriptine—Rhinitis—Topiramate—epilepsy syndrome	3.64e-05	0.000303	CcSEcCtD
Bromocriptine—Headache—Fosphenytoin—epilepsy syndrome	3.64e-05	0.000302	CcSEcCtD
Bromocriptine—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.63e-05	0.000302	CcSEcCtD
Bromocriptine—Asthenia—Phenytoin—epilepsy syndrome	3.62e-05	0.000301	CcSEcCtD
Bromocriptine—Nausea—Midazolam—epilepsy syndrome	3.62e-05	0.000301	CcSEcCtD
Bromocriptine—Hallucination—Topiramate—epilepsy syndrome	3.62e-05	0.000301	CcSEcCtD
Bromocriptine—Hypoaesthesia—Topiramate—epilepsy syndrome	3.62e-05	0.000301	CcSEcCtD
Bromocriptine—Muscle spasms—Gabapentin—epilepsy syndrome	3.62e-05	0.000301	CcSEcCtD
Bromocriptine—Tachycardia—Valproic Acid—epilepsy syndrome	3.61e-05	0.0003	CcSEcCtD
Bromocriptine—Diarrhoea—Zonisamide—epilepsy syndrome	3.61e-05	0.0003	CcSEcCtD
Bromocriptine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.61e-05	0.0003	CcSEcCtD
Bromocriptine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.61e-05	0.0003	CcSEcCtD
Bromocriptine—Vomiting—Vigabatrin—epilepsy syndrome	3.6e-05	0.000299	CcSEcCtD
Bromocriptine—Skin disorder—Valproic Acid—epilepsy syndrome	3.6e-05	0.000299	CcSEcCtD
Bromocriptine—Oedema peripheral—Topiramate—epilepsy syndrome	3.58e-05	0.000298	CcSEcCtD
Bromocriptine—Connective tissue disorder—Topiramate—epilepsy syndrome	3.57e-05	0.000297	CcSEcCtD
Bromocriptine—Nausea—Levetiracetam—epilepsy syndrome	3.57e-05	0.000297	CcSEcCtD
Bromocriptine—Rash—Vigabatrin—epilepsy syndrome	3.57e-05	0.000297	CcSEcCtD
Bromocriptine—Dizziness—Felbamate—epilepsy syndrome	3.56e-05	0.000296	CcSEcCtD
Bromocriptine—Dermatitis—Vigabatrin—epilepsy syndrome	3.56e-05	0.000296	CcSEcCtD
Bromocriptine—Convulsion—Pregabalin—epilepsy syndrome	3.55e-05	0.000295	CcSEcCtD
Bromocriptine—Vision blurred—Gabapentin—epilepsy syndrome	3.54e-05	0.000295	CcSEcCtD
Bromocriptine—Headache—Vigabatrin—epilepsy syndrome	3.54e-05	0.000295	CcSEcCtD
Bromocriptine—Hypertension—Pregabalin—epilepsy syndrome	3.54e-05	0.000294	CcSEcCtD
Bromocriptine—Vomiting—Diazepam—epilepsy syndrome	3.54e-05	0.000294	CcSEcCtD
Bromocriptine—Anorexia—Valproic Acid—epilepsy syndrome	3.53e-05	0.000293	CcSEcCtD
Bromocriptine—Rash—Diazepam—epilepsy syndrome	3.51e-05	0.000292	CcSEcCtD
Bromocriptine—Dermatitis—Diazepam—epilepsy syndrome	3.51e-05	0.000292	CcSEcCtD
Bromocriptine—Visual impairment—Topiramate—epilepsy syndrome	3.5e-05	0.000291	CcSEcCtD
Bromocriptine—Dizziness—Zonisamide—epilepsy syndrome	3.49e-05	0.00029	CcSEcCtD
Bromocriptine—Headache—Diazepam—epilepsy syndrome	3.49e-05	0.00029	CcSEcCtD
Bromocriptine—Anxiety—Pregabalin—epilepsy syndrome	3.48e-05	0.000289	CcSEcCtD
Bromocriptine—Diarrhoea—Clonazepam—epilepsy syndrome	3.48e-05	0.000289	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.47e-05	0.000288	CcSEcCtD
Bromocriptine—Hypotension—Valproic Acid—epilepsy syndrome	3.46e-05	0.000288	CcSEcCtD
Bromocriptine—Asthenia—Carbamazepine—epilepsy syndrome	3.46e-05	0.000288	CcSEcCtD
Bromocriptine—Agitation—Gabapentin—epilepsy syndrome	3.46e-05	0.000287	CcSEcCtD
Bromocriptine—Diarrhoea—Phenytoin—epilepsy syndrome	3.46e-05	0.000287	CcSEcCtD
Bromocriptine—Nausea—Fosphenytoin—epilepsy syndrome	3.45e-05	0.000287	CcSEcCtD
Bromocriptine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.44e-05	0.000286	CcSEcCtD
Bromocriptine—Vomiting—Felbamate—epilepsy syndrome	3.43e-05	0.000285	CcSEcCtD
Bromocriptine—Dry mouth—Pregabalin—epilepsy syndrome	3.42e-05	0.000284	CcSEcCtD
Bromocriptine—Rash—Felbamate—epilepsy syndrome	3.4e-05	0.000283	CcSEcCtD
Bromocriptine—Eye disorder—Topiramate—epilepsy syndrome	3.4e-05	0.000282	CcSEcCtD
Bromocriptine—Dermatitis—Felbamate—epilepsy syndrome	3.4e-05	0.000282	CcSEcCtD
Bromocriptine—Tinnitus—Topiramate—epilepsy syndrome	3.39e-05	0.000282	CcSEcCtD
Bromocriptine—Vertigo—Gabapentin—epilepsy syndrome	3.38e-05	0.000281	CcSEcCtD
Bromocriptine—Headache—Felbamate—epilepsy syndrome	3.38e-05	0.000281	CcSEcCtD
Bromocriptine—Confusional state—Pregabalin—epilepsy syndrome	3.38e-05	0.000281	CcSEcCtD
Bromocriptine—Cardiac disorder—Topiramate—epilepsy syndrome	3.37e-05	0.00028	CcSEcCtD
Bromocriptine—Syncope—Gabapentin—epilepsy syndrome	3.37e-05	0.00028	CcSEcCtD
Bromocriptine—Dizziness—Clonazepam—epilepsy syndrome	3.36e-05	0.00028	CcSEcCtD
Bromocriptine—Nausea—Vigabatrin—epilepsy syndrome	3.36e-05	0.000279	CcSEcCtD
Bromocriptine—Vomiting—Zonisamide—epilepsy syndrome	3.36e-05	0.000279	CcSEcCtD
Bromocriptine—Insomnia—Valproic Acid—epilepsy syndrome	3.35e-05	0.000278	CcSEcCtD
Bromocriptine—Oedema—Pregabalin—epilepsy syndrome	3.35e-05	0.000278	CcSEcCtD
Bromocriptine—Asthenia—Lamotrigine—epilepsy syndrome	3.34e-05	0.000278	CcSEcCtD
Bromocriptine—Dizziness—Phenytoin—epilepsy syndrome	3.34e-05	0.000278	CcSEcCtD
Bromocriptine—Rash—Zonisamide—epilepsy syndrome	3.33e-05	0.000277	CcSEcCtD
Bromocriptine—Infection—Pregabalin—epilepsy syndrome	3.33e-05	0.000276	CcSEcCtD
Bromocriptine—Paraesthesia—Valproic Acid—epilepsy syndrome	3.33e-05	0.000276	CcSEcCtD
Bromocriptine—Dermatitis—Zonisamide—epilepsy syndrome	3.32e-05	0.000276	CcSEcCtD
Bromocriptine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.32e-05	0.000276	CcSEcCtD
Bromocriptine—Nausea—Diazepam—epilepsy syndrome	3.31e-05	0.000275	CcSEcCtD
Bromocriptine—Loss of consciousness—Gabapentin—epilepsy syndrome	3.31e-05	0.000275	CcSEcCtD
Bromocriptine—Headache—Zonisamide—epilepsy syndrome	3.31e-05	0.000275	CcSEcCtD
Bromocriptine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.3e-05	0.000274	CcSEcCtD
Bromocriptine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.3e-05	0.000274	CcSEcCtD
Bromocriptine—Angiopathy—Topiramate—epilepsy syndrome	3.3e-05	0.000274	CcSEcCtD
Bromocriptine—Shock—Pregabalin—epilepsy syndrome	3.29e-05	0.000274	CcSEcCtD
Bromocriptine—Somnolence—Valproic Acid—epilepsy syndrome	3.29e-05	0.000274	CcSEcCtD
Bromocriptine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.28e-05	0.000273	CcSEcCtD
Bromocriptine—Mediastinal disorder—Topiramate—epilepsy syndrome	3.28e-05	0.000272	CcSEcCtD
Bromocriptine—Tachycardia—Pregabalin—epilepsy syndrome	3.27e-05	0.000272	CcSEcCtD
Bromocriptine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.26e-05	0.000271	CcSEcCtD
Bromocriptine—Convulsion—Gabapentin—epilepsy syndrome	3.26e-05	0.000271	CcSEcCtD
Bromocriptine—Skin disorder—Pregabalin—epilepsy syndrome	3.25e-05	0.00027	CcSEcCtD
Bromocriptine—Hypertension—Gabapentin—epilepsy syndrome	3.25e-05	0.00027	CcSEcCtD
Bromocriptine—Vomiting—Clonazepam—epilepsy syndrome	3.23e-05	0.000269	CcSEcCtD
Bromocriptine—Decreased appetite—Valproic Acid—epilepsy syndrome	3.22e-05	0.000268	CcSEcCtD
Bromocriptine—Alopecia—Topiramate—epilepsy syndrome	3.21e-05	0.000267	CcSEcCtD
Bromocriptine—Vomiting—Phenytoin—epilepsy syndrome	3.21e-05	0.000267	CcSEcCtD
Bromocriptine—Rash—Clonazepam—epilepsy syndrome	3.21e-05	0.000267	CcSEcCtD
Bromocriptine—Dermatitis—Clonazepam—epilepsy syndrome	3.2e-05	0.000266	CcSEcCtD
Bromocriptine—Nausea—Felbamate—epilepsy syndrome	3.2e-05	0.000266	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.2e-05	0.000266	CcSEcCtD
Bromocriptine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.19e-05	0.000266	CcSEcCtD
Bromocriptine—Fatigue—Valproic Acid—epilepsy syndrome	3.19e-05	0.000265	CcSEcCtD
Bromocriptine—Anxiety—Gabapentin—epilepsy syndrome	3.19e-05	0.000265	CcSEcCtD
Bromocriptine—Anorexia—Pregabalin—epilepsy syndrome	3.19e-05	0.000265	CcSEcCtD
Bromocriptine—Dizziness—Carbamazepine—epilepsy syndrome	3.19e-05	0.000265	CcSEcCtD
Bromocriptine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.19e-05	0.000265	CcSEcCtD
Bromocriptine—Headache—Clonazepam—epilepsy syndrome	3.19e-05	0.000265	CcSEcCtD
Bromocriptine—Rash—Phenytoin—epilepsy syndrome	3.19e-05	0.000265	CcSEcCtD
Bromocriptine—Mental disorder—Topiramate—epilepsy syndrome	3.18e-05	0.000265	CcSEcCtD
Bromocriptine—Dermatitis—Phenytoin—epilepsy syndrome	3.18e-05	0.000265	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.18e-05	0.000264	CcSEcCtD
Bromocriptine—Rash—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.000263	CcSEcCtD
Bromocriptine—Constipation—Valproic Acid—epilepsy syndrome	3.17e-05	0.000263	CcSEcCtD
Bromocriptine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.000263	CcSEcCtD
Bromocriptine—Headache—Phenytoin—epilepsy syndrome	3.16e-05	0.000263	CcSEcCtD
Bromocriptine—Headache—Oxcarbazepine—epilepsy syndrome	3.15e-05	0.000262	CcSEcCtD
Bromocriptine—Nausea—Zonisamide—epilepsy syndrome	3.13e-05	0.000261	CcSEcCtD
Bromocriptine—Dry mouth—Gabapentin—epilepsy syndrome	3.13e-05	0.00026	CcSEcCtD
Bromocriptine—Hypotension—Pregabalin—epilepsy syndrome	3.13e-05	0.00026	CcSEcCtD
Bromocriptine—Tension—Topiramate—epilepsy syndrome	3.11e-05	0.000258	CcSEcCtD
Bromocriptine—Dysgeusia—Topiramate—epilepsy syndrome	3.1e-05	0.000258	CcSEcCtD
Bromocriptine—Confusional state—Gabapentin—epilepsy syndrome	3.1e-05	0.000257	CcSEcCtD
Bromocriptine—ABCB1—brain—epilepsy syndrome	3.09e-05	0.000614	CbGeAlD
Bromocriptine—Dizziness—Lamotrigine—epilepsy syndrome	3.08e-05	0.000256	CcSEcCtD
Bromocriptine—Nervousness—Topiramate—epilepsy syndrome	3.07e-05	0.000256	CcSEcCtD
Bromocriptine—Oedema—Gabapentin—epilepsy syndrome	3.07e-05	0.000255	CcSEcCtD
Bromocriptine—Vomiting—Carbamazepine—epilepsy syndrome	3.07e-05	0.000255	CcSEcCtD
Bromocriptine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.05e-05	0.000254	CcSEcCtD
Bromocriptine—Infection—Gabapentin—epilepsy syndrome	3.05e-05	0.000254	CcSEcCtD
Bromocriptine—Muscle spasms—Topiramate—epilepsy syndrome	3.04e-05	0.000253	CcSEcCtD
Bromocriptine—Rash—Carbamazepine—epilepsy syndrome	3.04e-05	0.000253	CcSEcCtD
Bromocriptine—Dermatitis—Carbamazepine—epilepsy syndrome	3.04e-05	0.000253	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.03e-05	0.000252	CcSEcCtD
Bromocriptine—Insomnia—Pregabalin—epilepsy syndrome	3.03e-05	0.000252	CcSEcCtD
Bromocriptine—Nausea—Clonazepam—epilepsy syndrome	3.02e-05	0.000251	CcSEcCtD
Bromocriptine—Headache—Carbamazepine—epilepsy syndrome	3.02e-05	0.000251	CcSEcCtD
Bromocriptine—Shock—Gabapentin—epilepsy syndrome	3.02e-05	0.000251	CcSEcCtD
Bromocriptine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.01e-05	0.00025	CcSEcCtD
Bromocriptine—Paraesthesia—Pregabalin—epilepsy syndrome	3.01e-05	0.00025	CcSEcCtD
Bromocriptine—Nausea—Phenytoin—epilepsy syndrome	3e-05	0.000249	CcSEcCtD
Bromocriptine—Tachycardia—Gabapentin—epilepsy syndrome	3e-05	0.000249	CcSEcCtD
Bromocriptine—Dyspnoea—Pregabalin—epilepsy syndrome	2.98e-05	0.000248	CcSEcCtD
Bromocriptine—Nausea—Oxcarbazepine—epilepsy syndrome	2.98e-05	0.000248	CcSEcCtD
Bromocriptine—Vision blurred—Topiramate—epilepsy syndrome	2.98e-05	0.000248	CcSEcCtD
Bromocriptine—Skin disorder—Gabapentin—epilepsy syndrome	2.98e-05	0.000248	CcSEcCtD
Bromocriptine—Somnolence—Pregabalin—epilepsy syndrome	2.98e-05	0.000247	CcSEcCtD
Bromocriptine—Vomiting—Lamotrigine—epilepsy syndrome	2.96e-05	0.000246	CcSEcCtD
Bromocriptine—Urticaria—Valproic Acid—epilepsy syndrome	2.94e-05	0.000245	CcSEcCtD
Bromocriptine—Rash—Lamotrigine—epilepsy syndrome	2.94e-05	0.000244	CcSEcCtD
Bromocriptine—Dermatitis—Lamotrigine—epilepsy syndrome	2.94e-05	0.000244	CcSEcCtD
Bromocriptine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.93e-05	0.000243	CcSEcCtD
Bromocriptine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.93e-05	0.000243	CcSEcCtD
Bromocriptine—Anorexia—Gabapentin—epilepsy syndrome	2.93e-05	0.000243	CcSEcCtD
Bromocriptine—Headache—Lamotrigine—epilepsy syndrome	2.92e-05	0.000243	CcSEcCtD
Bromocriptine—Decreased appetite—Pregabalin—epilepsy syndrome	2.91e-05	0.000242	CcSEcCtD
Bromocriptine—Agitation—Topiramate—epilepsy syndrome	2.91e-05	0.000242	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.89e-05	0.00024	CcSEcCtD
Bromocriptine—Fatigue—Pregabalin—epilepsy syndrome	2.89e-05	0.00024	CcSEcCtD
Bromocriptine—Hypotension—Gabapentin—epilepsy syndrome	2.87e-05	0.000238	CcSEcCtD
Bromocriptine—Nausea—Carbamazepine—epilepsy syndrome	2.86e-05	0.000238	CcSEcCtD
Bromocriptine—Constipation—Pregabalin—epilepsy syndrome	2.86e-05	0.000238	CcSEcCtD
Bromocriptine—Vertigo—Topiramate—epilepsy syndrome	2.84e-05	0.000236	CcSEcCtD
Bromocriptine—Syncope—Topiramate—epilepsy syndrome	2.84e-05	0.000236	CcSEcCtD
Bromocriptine—Loss of consciousness—Topiramate—epilepsy syndrome	2.78e-05	0.000231	CcSEcCtD
Bromocriptine—Insomnia—Gabapentin—epilepsy syndrome	2.78e-05	0.000231	CcSEcCtD
Bromocriptine—Nausea—Lamotrigine—epilepsy syndrome	2.77e-05	0.00023	CcSEcCtD
Bromocriptine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.76e-05	0.000229	CcSEcCtD
Bromocriptine—Paraesthesia—Gabapentin—epilepsy syndrome	2.76e-05	0.000229	CcSEcCtD
Bromocriptine—Convulsion—Topiramate—epilepsy syndrome	2.74e-05	0.000228	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.74e-05	0.000228	CcSEcCtD
Bromocriptine—Dyspnoea—Gabapentin—epilepsy syndrome	2.74e-05	0.000228	CcSEcCtD
Bromocriptine—Hypertension—Topiramate—epilepsy syndrome	2.73e-05	0.000227	CcSEcCtD
Bromocriptine—Somnolence—Gabapentin—epilepsy syndrome	2.73e-05	0.000227	CcSEcCtD
Bromocriptine—Dyspepsia—Gabapentin—epilepsy syndrome	2.7e-05	0.000225	CcSEcCtD
Bromocriptine—Anxiety—Topiramate—epilepsy syndrome	2.68e-05	0.000223	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.68e-05	0.000222	CcSEcCtD
Bromocriptine—Decreased appetite—Gabapentin—epilepsy syndrome	2.67e-05	0.000222	CcSEcCtD
Bromocriptine—Urticaria—Pregabalin—epilepsy syndrome	2.66e-05	0.000221	CcSEcCtD
Bromocriptine—Asthenia—Valproic Acid—epilepsy syndrome	2.66e-05	0.000221	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.65e-05	0.00022	CcSEcCtD
Bromocriptine—Fatigue—Gabapentin—epilepsy syndrome	2.65e-05	0.00022	CcSEcCtD
Bromocriptine—Body temperature increased—Pregabalin—epilepsy syndrome	2.65e-05	0.00022	CcSEcCtD
Bromocriptine—Abdominal pain—Pregabalin—epilepsy syndrome	2.65e-05	0.00022	CcSEcCtD
Bromocriptine—Dry mouth—Topiramate—epilepsy syndrome	2.63e-05	0.000219	CcSEcCtD
Bromocriptine—Constipation—Gabapentin—epilepsy syndrome	2.63e-05	0.000218	CcSEcCtD
Bromocriptine—Confusional state—Topiramate—epilepsy syndrome	2.6e-05	0.000216	CcSEcCtD
Bromocriptine—Oedema—Topiramate—epilepsy syndrome	2.58e-05	0.000215	CcSEcCtD
Bromocriptine—Infection—Topiramate—epilepsy syndrome	2.57e-05	0.000213	CcSEcCtD
Bromocriptine—Shock—Topiramate—epilepsy syndrome	2.54e-05	0.000211	CcSEcCtD
Bromocriptine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.53e-05	0.000211	CcSEcCtD
Bromocriptine—Nervous system disorder—Topiramate—epilepsy syndrome	2.53e-05	0.000211	CcSEcCtD
Bromocriptine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.53e-05	0.00021	CcSEcCtD
Bromocriptine—Tachycardia—Topiramate—epilepsy syndrome	2.52e-05	0.00021	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.51e-05	0.000209	CcSEcCtD
Bromocriptine—Skin disorder—Topiramate—epilepsy syndrome	2.51e-05	0.000209	CcSEcCtD
Bromocriptine—Anorexia—Topiramate—epilepsy syndrome	2.46e-05	0.000205	CcSEcCtD
Bromocriptine—Dizziness—Valproic Acid—epilepsy syndrome	2.45e-05	0.000204	CcSEcCtD
Bromocriptine—Urticaria—Gabapentin—epilepsy syndrome	2.44e-05	0.000203	CcSEcCtD
Bromocriptine—Body temperature increased—Gabapentin—epilepsy syndrome	2.43e-05	0.000202	CcSEcCtD
Bromocriptine—Abdominal pain—Gabapentin—epilepsy syndrome	2.43e-05	0.000202	CcSEcCtD
Bromocriptine—Hypotension—Topiramate—epilepsy syndrome	2.41e-05	0.000201	CcSEcCtD
Bromocriptine—Asthenia—Pregabalin—epilepsy syndrome	2.4e-05	0.0002	CcSEcCtD
Bromocriptine—Vomiting—Valproic Acid—epilepsy syndrome	2.35e-05	0.000196	CcSEcCtD
Bromocriptine—Insomnia—Topiramate—epilepsy syndrome	2.34e-05	0.000194	CcSEcCtD
Bromocriptine—Rash—Valproic Acid—epilepsy syndrome	2.33e-05	0.000194	CcSEcCtD
Bromocriptine—Dermatitis—Valproic Acid—epilepsy syndrome	2.33e-05	0.000194	CcSEcCtD
Bromocriptine—Headache—Valproic Acid—epilepsy syndrome	2.32e-05	0.000193	CcSEcCtD
Bromocriptine—Paraesthesia—Topiramate—epilepsy syndrome	2.32e-05	0.000193	CcSEcCtD
Bromocriptine—Dyspnoea—Topiramate—epilepsy syndrome	2.3e-05	0.000191	CcSEcCtD
Bromocriptine—Somnolence—Topiramate—epilepsy syndrome	2.3e-05	0.000191	CcSEcCtD
Bromocriptine—Diarrhoea—Pregabalin—epilepsy syndrome	2.29e-05	0.00019	CcSEcCtD
Bromocriptine—Dyspepsia—Topiramate—epilepsy syndrome	2.27e-05	0.000189	CcSEcCtD
Bromocriptine—Decreased appetite—Topiramate—epilepsy syndrome	2.25e-05	0.000187	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.23e-05	0.000185	CcSEcCtD
Bromocriptine—Fatigue—Topiramate—epilepsy syndrome	2.23e-05	0.000185	CcSEcCtD
Bromocriptine—Dizziness—Pregabalin—epilepsy syndrome	2.21e-05	0.000184	CcSEcCtD
Bromocriptine—Constipation—Topiramate—epilepsy syndrome	2.21e-05	0.000184	CcSEcCtD
Bromocriptine—Asthenia—Gabapentin—epilepsy syndrome	2.2e-05	0.000183	CcSEcCtD
Bromocriptine—Nausea—Valproic Acid—epilepsy syndrome	2.2e-05	0.000183	CcSEcCtD
Bromocriptine—Vomiting—Pregabalin—epilepsy syndrome	2.13e-05	0.000177	CcSEcCtD
Bromocriptine—Feeling abnormal—Topiramate—epilepsy syndrome	2.13e-05	0.000177	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.11e-05	0.000176	CcSEcCtD
Bromocriptine—Rash—Pregabalin—epilepsy syndrome	2.11e-05	0.000175	CcSEcCtD
Bromocriptine—Dermatitis—Pregabalin—epilepsy syndrome	2.11e-05	0.000175	CcSEcCtD
Bromocriptine—Diarrhoea—Gabapentin—epilepsy syndrome	2.1e-05	0.000175	CcSEcCtD
Bromocriptine—Headache—Pregabalin—epilepsy syndrome	2.1e-05	0.000174	CcSEcCtD
Bromocriptine—Urticaria—Topiramate—epilepsy syndrome	2.05e-05	0.000171	CcSEcCtD
Bromocriptine—Abdominal pain—Topiramate—epilepsy syndrome	2.04e-05	0.00017	CcSEcCtD
Bromocriptine—Body temperature increased—Topiramate—epilepsy syndrome	2.04e-05	0.00017	CcSEcCtD
Bromocriptine—Dizziness—Gabapentin—epilepsy syndrome	2.03e-05	0.000169	CcSEcCtD
Bromocriptine—Nausea—Pregabalin—epilepsy syndrome	1.99e-05	0.000165	CcSEcCtD
Bromocriptine—Vomiting—Gabapentin—epilepsy syndrome	1.95e-05	0.000162	CcSEcCtD
Bromocriptine—Rash—Gabapentin—epilepsy syndrome	1.94e-05	0.000161	CcSEcCtD
Bromocriptine—Dermatitis—Gabapentin—epilepsy syndrome	1.93e-05	0.000161	CcSEcCtD
Bromocriptine—Headache—Gabapentin—epilepsy syndrome	1.92e-05	0.00016	CcSEcCtD
Bromocriptine—Asthenia—Topiramate—epilepsy syndrome	1.85e-05	0.000154	CcSEcCtD
Bromocriptine—Nausea—Gabapentin—epilepsy syndrome	1.82e-05	0.000152	CcSEcCtD
Bromocriptine—Diarrhoea—Topiramate—epilepsy syndrome	1.77e-05	0.000147	CcSEcCtD
Bromocriptine—Dizziness—Topiramate—epilepsy syndrome	1.71e-05	0.000142	CcSEcCtD
Bromocriptine—Vomiting—Topiramate—epilepsy syndrome	1.64e-05	0.000137	CcSEcCtD
Bromocriptine—Rash—Topiramate—epilepsy syndrome	1.63e-05	0.000135	CcSEcCtD
Bromocriptine—Dermatitis—Topiramate—epilepsy syndrome	1.63e-05	0.000135	CcSEcCtD
Bromocriptine—Headache—Topiramate—epilepsy syndrome	1.62e-05	0.000135	CcSEcCtD
Bromocriptine—Nausea—Topiramate—epilepsy syndrome	1.53e-05	0.000128	CcSEcCtD
Bromocriptine—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	9.16e-07	1.07e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	9.16e-07	1.07e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	9.15e-07	1.06e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	9.15e-07	1.06e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	9.11e-07	1.06e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	9.09e-07	1.06e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	9.08e-07	1.06e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—RELA—epilepsy syndrome	9.06e-07	1.05e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	9.04e-07	1.05e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	9e-07	1.05e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	8.99e-07	1.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	8.99e-07	1.05e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	8.97e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	8.97e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	8.96e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	8.96e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—TH—epilepsy syndrome	8.96e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	8.94e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—RELA—epilepsy syndrome	8.94e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—POMC—epilepsy syndrome	8.92e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	8.9e-07	1.04e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	8.89e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	8.88e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	8.88e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	8.86e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	8.85e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	8.82e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.82e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—JUN—epilepsy syndrome	8.82e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	8.82e-07	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	8.78e-07	1.02e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	8.78e-07	1.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	8.77e-07	1.02e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	8.77e-07	1.02e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	8.76e-07	1.02e-05	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	8.75e-07	1.02e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	8.72e-07	1.01e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	8.7e-07	1.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	8.7e-07	1.01e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	8.69e-07	1.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	8.69e-07	1.01e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	8.67e-07	1.01e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	8.65e-07	1.01e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	8.64e-07	1e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	8.6e-07	1e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	8.58e-07	9.98e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	8.51e-07	9.9e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	8.46e-07	9.84e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	8.42e-07	9.79e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	8.39e-07	9.76e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GPX1—epilepsy syndrome	8.36e-07	9.72e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	8.35e-07	9.71e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	8.33e-07	9.69e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	8.32e-07	9.68e-06	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	8.27e-07	9.62e-06	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—SRC—epilepsy syndrome	8.26e-07	9.61e-06	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.25e-07	9.6e-06	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	8.21e-07	9.55e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	8.2e-07	9.54e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	8.19e-07	9.53e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	8.19e-07	9.53e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	8.17e-07	9.51e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	8.16e-07	9.49e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	8.16e-07	9.49e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	8.15e-07	9.48e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	8.14e-07	9.47e-06	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	8.14e-07	9.47e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ALB—epilepsy syndrome	8.14e-07	9.46e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	8.12e-07	9.45e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	8.07e-07	9.39e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	8.06e-07	9.38e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	8.06e-07	9.38e-06	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	8.06e-07	9.37e-06	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	8.05e-07	9.36e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	8.04e-07	9.35e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	8.03e-07	9.34e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	8.02e-07	9.33e-06	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	8e-07	9.3e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	7.99e-07	9.3e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	7.99e-07	9.29e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	7.94e-07	9.24e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	7.94e-07	9.23e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	7.92e-07	9.21e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—SRC—epilepsy syndrome	7.91e-07	9.2e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	7.86e-07	9.14e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	7.83e-07	9.11e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	7.83e-07	9.11e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	7.83e-07	9.11e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	7.79e-07	9.06e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	7.76e-07	9.03e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	7.75e-07	9.02e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	7.72e-07	8.98e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	7.7e-07	8.96e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	7.64e-07	8.89e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	7.62e-07	8.86e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	7.62e-07	8.86e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	7.6e-07	8.84e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	7.55e-07	8.78e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	7.54e-07	8.77e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	7.49e-07	8.71e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	7.48e-07	8.7e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	7.46e-07	8.68e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	7.42e-07	8.63e-06	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.42e-07	8.63e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	7.39e-07	8.6e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	7.39e-07	8.6e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	7.39e-07	8.6e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	7.39e-07	8.59e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAT—epilepsy syndrome	7.38e-07	8.58e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	7.37e-07	8.57e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	7.36e-07	8.56e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	7.35e-07	8.55e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.35e-07	8.55e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	7.35e-07	8.55e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AGT—epilepsy syndrome	7.33e-07	8.53e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	7.3e-07	8.49e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	7.28e-07	8.47e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	7.28e-07	8.46e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	7.25e-07	8.44e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOE—epilepsy syndrome	7.18e-07	8.35e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	7.18e-07	8.35e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	7.14e-07	8.3e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	7.12e-07	8.28e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	7.12e-07	8.28e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	7.1e-07	8.26e-06	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.09e-07	8.25e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	7.07e-07	8.23e-06	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	7.06e-07	8.21e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	7.03e-07	8.18e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	7.03e-07	8.17e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	7.03e-07	8.17e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	7.02e-07	8.16e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	6.99e-07	8.13e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	6.94e-07	8.08e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.94e-07	8.07e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	6.94e-07	8.07e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TH—epilepsy syndrome	6.92e-07	8.04e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	6.88e-07	8e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	6.86e-07	7.98e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	6.84e-07	7.96e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	6.84e-07	7.96e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	6.84e-07	7.96e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	6.83e-07	7.94e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	6.8e-07	7.91e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	6.79e-07	7.9e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.76e-07	7.86e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	6.73e-07	7.83e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	6.73e-07	7.83e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	6.71e-07	7.8e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	6.69e-07	7.79e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	6.67e-07	7.76e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	6.67e-07	7.76e-06	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	6.66e-07	7.75e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	6.64e-07	7.73e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	6.61e-07	7.69e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	6.61e-07	7.68e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	6.6e-07	7.68e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	6.6e-07	7.67e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	6.59e-07	7.67e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	6.5e-07	7.56e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	6.46e-07	7.52e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	6.44e-07	7.49e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	6.43e-07	7.48e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	6.41e-07	7.45e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	6.4e-07	7.45e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	6.34e-07	7.38e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	6.33e-07	7.36e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	6.24e-07	7.25e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	6.23e-07	7.25e-06	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.23e-07	7.24e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	6.18e-07	7.19e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	6.17e-07	7.18e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—POMC—epilepsy syndrome	6.17e-07	7.18e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	6.14e-07	7.14e-06	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.13e-07	7.13e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	6.12e-07	7.12e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	6.12e-07	7.12e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	6.09e-07	7.09e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	6.07e-07	7.06e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	6.01e-07	6.99e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	6e-07	6.98e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	5.99e-07	6.97e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.96e-07	6.94e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	5.95e-07	6.92e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	5.93e-07	6.9e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	5.93e-07	6.89e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	5.9e-07	6.86e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AGT—epilepsy syndrome	5.85e-07	6.81e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	5.83e-07	6.78e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	5.83e-07	6.78e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	5.78e-07	6.72e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.77e-07	6.71e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	5.77e-07	6.71e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	5.74e-07	6.67e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—epilepsy syndrome	5.73e-07	6.67e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.7e-07	6.62e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	5.68e-07	6.61e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	5.66e-07	6.58e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—epilepsy syndrome	5.63e-07	6.54e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	5.62e-07	6.54e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.58e-07	6.49e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.57e-07	6.47e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.54e-07	6.44e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	5.52e-07	6.43e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.45e-07	6.34e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.38e-07	6.25e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	5.37e-07	6.24e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	5.29e-07	6.15e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.24e-07	6.09e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	5.22e-07	6.07e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	5.18e-07	6.03e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.15e-07	5.99e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.15e-07	5.99e-06	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	5.14e-07	5.98e-06	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	5.14e-07	5.97e-06	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	5.1e-07	5.93e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.06e-07	5.89e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.05e-07	5.87e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	5e-07	5.81e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.93e-07	5.73e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.92e-07	5.72e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	4.92e-07	5.72e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	4.81e-07	5.6e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	4.69e-07	5.46e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.69e-07	5.45e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.52e-07	5.25e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.49e-07	5.22e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	4.43e-07	5.15e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.43e-07	5.15e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	4.4e-07	5.12e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	4.37e-07	5.08e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	4.37e-07	5.08e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	3.98e-07	4.63e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	3.94e-07	4.59e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.93e-07	4.57e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.81e-07	4.43e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.8e-07	4.42e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	3.79e-07	4.4e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	3.68e-07	4.28e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	3.62e-07	4.22e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	3.58e-07	4.16e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.47e-07	4.03e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.34e-07	3.89e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.29e-07	3.82e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	3.22e-07	3.74e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.03e-07	3.53e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	2.99e-07	3.48e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.47e-07	2.88e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.97e-07	2.3e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.52e-07	1.77e-06	CbGpPWpGaD
